46
Gram Positive Cocci

Staphylococci 09 10 Med

Embed Size (px)

DESCRIPTION

 

Citation preview

Page 1: Staphylococci 09 10  Med

Gram Positive Cocci

Page 2: Staphylococci 09 10  Med

Gram positive Staphylococci

Objective

• To know the general characters of the genus Staphylococcus

• To know how to differentiate between staphylococci and other gram-positive cocci

• To know the virulence factors associated with staphylococci

• To know the clinical infections associated with staphylococci

• To know the differential tests that used to identify the clinically relevant staphylococcus species

• To know the methicillin resistance in a serious of clinical problem

Page 3: Staphylococci 09 10  Med

STAPHYLOCOCCI

Staphyle (Greek) Bunch of grapes or BerriesCocci (Rounded)

General Characteristics•Gram positive cocci Arranged in grape like clusters •Facultative anaerobic •Catalase-positive•Grow in ordinary culture media (Nutrient agar and broth)

Page 4: Staphylococci 09 10  Med

Species of Staphylococci

33 species known

Three are medically important:

•S. aureus

•S. epidermidis

•S. saprophyticus

Page 5: Staphylococci 09 10  Med

STAPHYLOCOCCUS AUREUS

Morphology & Cultural Characters

• Staphyle - bunch of grapes

• Aureus - golden color colonies

• On blood agar - beta-hemolytic colonies

In contrast to other Staphylococci Can grow in 7.5% NaCl & basis of mannitol

ferment mannitol salt agar as selective medium for S.aureus

Page 6: Staphylococci 09 10  Med

Staphylococcal cell wall structure

Capsule orpolysaccharideslime layer

Phospholipid

PBP PBP

Transport protein

Cytoplasmic membrane

Protein A

Peptidoglycanlayer

Techoic acid

Capsule Antigenic & Antiphagocytic

Teichoic acid •Binds to fibronectins on surface of host cells

Protein AHas great affinity to Fc portion of IgG and makes it unavailable to its receptors on phagocyte

Page 7: Staphylococci 09 10  Med

Coagulase

Fibrin ClotFibrinogen

EXTRACELLULAR ENZYMES

The clot coats the organisms and inhibit their phagocytosis

1. Coagulase

Page 8: Staphylococci 09 10  Med

2. Catalase

May prevent killing of S. aureus by PMNLs cells

EXTRACELLULAR ENZYMES

Catalase

H2O2 Water O2+

Page 9: Staphylococci 09 10  Med

EXTRACELLULAR ENZYMES

3. Lipase

4. Hyaluronidase

5. Protease

6. DNAase

7. Penicillinase

Page 10: Staphylococci 09 10  Med

TOXINS OF S. AUREUS

1. Cytolytic toxins (Haemolysins & Leukocidins)

A- Haemolysins (hemolyzing RBCs)

, hemolysin: hemolyzing RBCs and destroying platelets

, hemolysin: als known as hot-cold lysin, enhances haemolytic activity when incubated at 370 C and 40C

δ hemolysin: less lethal than and tHaemolysins.

B-Leukocidins

Is an exotoxin lethal to PMNs also it has been implicated to as contributing to invasiveness of the organisms by suppressing phagocytosis

2. Exfoliatins (epidermolytic)

Cause nerosis of epidermis (locally or at other sites)

Page 11: Staphylococci 09 10  Med

TOXINS BY S. AUREUS

3. Toxic shock syndrome toxin (TSST-1)

•Stimulates macrophages to produce IL-1 & TNF-alpha

•Multiple effects toxic shock

4. Enterotoxins

•Resist boiling for 30 min.

•Resist gastrointestinal enzymes.

•Act on neuronal receptors in upper GIT

•Cause gastroenteritis in 1-5 hours after ingestion

Page 12: Staphylococci 09 10  Med

Diseases by S. aureus

PyogenicDue to toxins

Superficial Deep

Page 13: Staphylococci 09 10  Med

S. AUREUS DISEASESI: PYOGENIC INFECTIONS

A. Superficial

1. Furuncle (boil) •Infection of hair follicle, sweat gland, sebaceous glands

•Blockage of ducts predispose to infections like

acne vulgaris & stye

2. Carbuncle•(Furuncle + Inflammation of subcutaneous tissue)

•Can lead to abscess formation and bacteremia

Page 14: Staphylococci 09 10  Med

Furuncle Folliculitis

Page 15: Staphylococci 09 10  Med

3. Paroncyhia•Infection of nail bed •Can be autoinfection OR from an external source

4. Postoperative wound infections

•Autoinfection or from carriers like doctors and nurses

5. Nosocomial (hospital acquired) infections

A common cause

S. AUREUS DISEASES

Page 16: Staphylococci 09 10  Med

I: PYOGENIC INFECTIONS

B. Deep Infections Usually caused by bacteremic spread

1. Osteomyelitis and arthritis

3. Bronchopneumonia

4. Empyema thoracis

5. Meningitis

6. UTI

7. Endocarditis: in drug abusers using injections

S. AUREUS DISEASES

Page 17: Staphylococci 09 10  Med

S. AUREUS DISEASES II: DISEASES DUE TO TOXINS

Exfoliatin inStaph lesion

Toxemia

Necrosis of epidermis

Loose skin(vesicles)

Vesicles breakup

Staph not isolated from lesions

1. Scalded Skin Syndrome (SSS)

Page 18: Staphylococci 09 10  Med

Staphylococcus Scalded Skin Syndrome (SSSS)

Page 19: Staphylococci 09 10  Med

2. Impetigo •Localized SSS •Produce blisters that contain pus and Staph

3. Scarlet Fever•Mild form of SSS•Characterized by erythema without vesicles

S. AUREUS DISEASES II: DISEASES DUE TO TOXINS

Page 20: Staphylococci 09 10  Med

4. Toxic Shock Syndrome (TSS)

• Occur in young women during and immediately after menstruation

• Due to intravaginal use of tampons infected with S. aureus produce TSS

• Fever, vomiting, diarrhea, body pain within 48 hours severe shock

S. AUREUS DISEASES II: DISEASES DUE TO TOXINS

Page 21: Staphylococci 09 10  Med

Staph multiplication

Enterotoxinin food

Resists reheating

Acute vomiting &diarrhoea (1-5 hrs)

Food ingested

5. Staph Food Intoxication

Poorreferigeration

Staph Carrier

Salads, potatocreamy dishes

Contaminates

S. AUREUS DISEASES II: DISEASES DUE TO TOXINS

Page 22: Staphylococci 09 10  Med

TREATMENT OF STAPH INFECTIONS

Drainage of pus in superficial and chronic lesions

C/S to select proper antibiotics

Severe infections

Amoxycillin-clavulinic acid (Augumentin)

Chronic infections

MRSA (methicillin-resistant S. aureus)

Vancomycin

VRSA (Vancomycin Resistant S.aureus) &

VISA (Vancomycin Intermediate S.aureus)

Linezolid & Quinupristin-Dalfopristin

Page 23: Staphylococci 09 10  Med

•1940s : all S.aureus were sensitive to penicillin•Shortly after use : penicillin resistant strains appeared which produced beta-lactamase - rapidly spread

•In late 1950s : beta-lactamase - resistant penicillin (methicillin) was introduced•In 1961 methicillin-resistant S. aureus (MRSA) was discovered (presently a major problem)•In 1996 Vancomycin Intermediate S. aureus (VISA)•In 1997 Vancomycin Resistant S. aureus (VRSA)

ANTIBIOTICS RESISTANCE Historical aspect

Page 24: Staphylococci 09 10  Med

STAPHYLOCOCCAL NASAL CARRIER

Anterior nose of 20-40% of adults are carriers•Physicians & nurses = 50-70% •Also skin of axillae & perineum•In hospital - high carrier rate due to environmental load

MRSA •Low carriage rate in community•High in tertiary care hospitals

Mode of Transmission•Fomites•Direct from hospital staff or attendants : contaminated hands

Page 25: Staphylococci 09 10  Med

Control of Carrier and Re-infection

•Wash clothes in hot water (>70oC)

•Hand washing with antiseptic soap (Dettol soap)

•Antimicrobial nasal cream (Gentamicin/Mupirocin)

•Oral antibiotics that are concentrated in nasal secretions (ciprofloxacin and rifampicin)

Chemoprophylaxis•Antibiotics before and at time of surgical operation

Page 26: Staphylococci 09 10  Med

COAGULASE-NEGATIVE STAPHYLOCOCCI

Medically important species:1. S. epidermidis2. S. saprophyticus

Page 27: Staphylococci 09 10  Med

STAPHYLOCOCCUS EPIDERMIDIS

•Normal flora in °Skin

°Anterior nose &

°External ear canal

•White, non-haemolytic colonies on blood agar

•Sensitive to novobiocin; (S. saprophyticus is resistant)

Page 28: Staphylococci 09 10  Med

DISEASES BY S. EPIDERMIDIS

•Most infections are hospital acquired

•Opportunistic pathogen in immuno-suppressed

•Strongly associated with presence of foreign bodies

° Prosthetic heart valves (endocarditis)

° IV catheters (bacteremia)

° Urinary catheter (UTI in elderly)

° CSF shunts (meningitis)

° Peritoneal dialysis catheter (peritonitis)

Page 29: Staphylococci 09 10  Med
Page 30: Staphylococci 09 10  Med

STAPHYLOCOCUS SAPROPHYTICUS

•Saprophytic life

•Resistant to novobiocin

•Most infections are community-acquired

•Primary UTI in 10-20% of young adult women – hormonal factors may be involved.

•Resistant to antibiotics – penicillins & cephalosporins

Page 31: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

Specimens

• Pus, sputum

• Blood, CSF

• Feces, vomit and left over food – in food poisoning

• Anterior nasal swab for carriers

Page 32: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

Microscopy

•G+ve cocci in clusters

Culture

•Blood agar - golden yellow colonies with

beta-haemolysis

•Mannitol salt agar - yellow colonies (selective and differential for isolation from faeces)

Page 33: Staphylococci 09 10  Med

Sputum smear  Staphylococcus aureus

Staphylococcus & Streptococcus pneumoniae

Page 34: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

Biochemical Tests

Catalase TestDifferentiates between Staphylococci (positive) & Streptococci (negative)

H2O2 Water + OxygenCatalase

•Pour 2-3 ml of H2O2 in a test tube

•With a sterile wooden stick pick a good growth of the

organism (from blood free medium) and immerse in H2O2

•Immediate active bubbles – positive test

Page 35: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

Biochemical Tests

Coagulase Test (positive)•Differentiates between S. aureus (positive) and other staphylococci (negative)

Slide Method (for bound coagulase)•Place a drop of saline on two separate slides.

•Emulsify a colony of test organism in each drop to make thick suspension.

•Add a drop of plasma to one suspension and mix gently.

•Look for clumping within 10 sec for positive test.

Page 36: Staphylococci 09 10  Med

EXTRACELLULAR ENZYMES

Coagulase

Activates

CRF* (Prothrombin) in plasma

*CRF : Coagulase Reacting Factor

Clot FibrinogenFibrin

Activated CRF

1. Coagulasea) Free coagulase (soluble):

•Converts fibrinogen to fibrin -clot formation•The clot coats the organisms and inhibit their phagocytosis•Detected by tube coagulase test (positive in 3-4 hours)

Page 37: Staphylococci 09 10  Med

Coagulase

Fibrin ClotFibrinogen

EXTRACELLULAR ENZYMES

•Converts fibrinogen to fibrin -clot formation•The clot coats the organisms and inhibit their phagocytosis•Detected by slide coagulase test (positive in few min)

2. Bound coagulase

Page 38: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

Biochemical TestsTube Method (for free coagulase)

1. Mix 0.2 ml of plasma with 1.8 ml of saline (1:10 dil)

2. Take three small test tubes and label•T (Test organism) = (18-24 hr broth culture)

•Pos (Positive control) = (18-24 hr broth culture)

•Neg (Negative control) = (Sterile broth)

Page 39: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

3. Pipette 0.5 ml of diluted plasma into each tube

4. Add 5 drops of test organism in tube “T”

5. Add 5 drops of S. aureus culture to tube “Pos”.

6. Add 5 drops of sterile broth to tube ‘Neg’

7.Mix gently and incubate at 37oC for 1 hr.

8. Examine for clotting each hr : upto 6 hours.

Page 40: Staphylococci 09 10  Med

LAB IDENTIFICATION OF S. AUREUS

DNASE TEST•Differentiates S. aureus (positive)) from other Stpahylococci (negative)

•Culture test organism DNA agar (S. aureus will hydrolyse DNA around the colonies)

•After 24 hrs incubation pour weak HCl on surface of plate

•The acid will ppt. unhydrolyzed DNA and DNAse producing colonies are surrounded by clear areas within 5 min.

•Clear zones: S. aureus – DNAse +ve•No clearing around colonies – DNAse -ve

Page 41: Staphylococci 09 10  Med

Case study #1

An elderly male was admitted to CCU with myocardial infarction. He was helped with IV lines and urinary catheter. On 5th day of his stay, he was found to have :

1. High grade temperature. 2. The physician noticed redness around IV

line.3. Chest X-ray showed normal lung fields. 4. Blood culture showed gram-positive cocci

in clusters5. Growth on blood agar had coagulase-

negative bacteria

Page 42: Staphylococci 09 10  Med

Questions

1. What is the identity of the organism ?

2. What type of infection it is ?3. What is the source of organism ?4. What is antibiotic treatment of the

patient ?5. What will you do if the organism is

resistant to vancomycin ?

Page 43: Staphylococci 09 10  Med

Case study #2

An elderly male was admitted to CCU with myocardial infarction. On 5th day of his stay, he was found to have :

1. High temperature with cough and purulent sputum

2. Chest X-ray showed multiple abscesses

3. Sputum Gram-smear showed Gram-positive cocci in clusters

4. Growth on blood agar had coagulase-positive bacteria

Page 44: Staphylococci 09 10  Med

Questions

1. What is the identity of the organism ?

2. What type of infection it is ?3. What is the source of organism ?4. What is antibiotic treatment of the

patient ?5. What you will do if the organism is

MRSA ?

Page 45: Staphylococci 09 10  Med

Case study #3

A19-year-old women complained of fever and flank pain, dysuria, urgency to urinate, and blood-tinged urine were also noted. A urine analysis revealed many WBCs and WBCs cast. A urine culture grew white nonhemolytic colonies on blood agar. The colony count was 45,000 CFU/ml. No growth appeared on MacConkey’s agar. The organism was catalase positive and slide-and tube coagulase negative and produced a 21-mm zone of inhibition in the presence of novnbiocin disc

Page 46: Staphylococci 09 10  Med

Questions

•What is the identity of the isolate?

In what patient population does this organism normally cause infection?